336
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Polymorphisms in genes involved in the free-radical process in patients with sudden sensorineural hearing loss and Ménière's disease

, , , , , , , , , , & show all
Pages 498-506 | Received 22 Feb 2013, Accepted 04 Apr 2013, Published online: 07 May 2013

References

  • Schreiber BE, Agrup C, Haskard DO, Luxon LM. Sudden sensorineural hearing loss. Lancet 2010;375:1203–1211.
  • Merchant SN, Adams JC, Nadol JB Jr. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2005;26:151–160.
  • Hallpike SC, Cairns H. Observations on the pathology of Meniere's syndrome. J Laryngol Otol 1938;53:625–655.
  • Yamakawa K. Uber die pathologisch Veranderung bei einem Meniere-Kranken. J Otorhinolaryngol Soc Jpn 1938;4: 2310–2312.
  • Labbe D, Teranishi M, Hess A, Bloch W, Michel O. Activation of caspase-3 is associated with oxidative stress in the hydropic guinea pig cochlea. Hear Res 2005;202:21–27.
  • Capaccio P, Pignataro L, Gaini LM, Sigismund PE, Novembrino C, De Giuseppe R, et al. Unbalanced oxidative status in idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2012;269:449–453.
  • Calabrese V, Cornelius C, Maiolino L, Luca M, Chiaramonte R, Toscano MA, Serra A. Oxidative stress, redox homeostasis and cellular stress response in Meniere's disease: role of vitagenes. Neurochem Res 2010;35:2208–2217.
  • Capaccio P, Cuccarini V, Ottaviani F, Fracchiolla NS, Bossi A, Pignataro L. Prothrombotic gene mutations in patients with sudden sensorineural hearing loss and cardiovascular thrombotic disease. Ann Otol Rhinol Laryngol 2009;118:205–210.
  • Capaccio P, Ottaviani F, Cuccarini V, Ambrosetti U, Fagnani E, Bottero A, et al. Methylenetetrahydrofolate reductase gene mutations as risk factors for sudden hearing loss. Am J Otolaryngol 2005;26:383–387.
  • Capaccio P, Ottaviani F, Cuccarini V, Ambrosetti U, Fagnani E, Bottero A, et al. Sudden hearing loss and MTHFR 677C> T/1298A> C gene polymorphisms. Genet Med 2005;7:206–208.
  • Capaccio P, Ottaviani F, Cuccarini V, Bottero A, Schindler A, Cesana BM, et al. Genetic and acquired prothrombotic risk factors and sudden hearing loss. Laryngoscope 2007;117:547–551.
  • Furuta T, Teranishi M, Uchida Y, Nishio N, Kato K, Otake H, et al. Association of interleukin-1 gene polymorphisms with sudden sensorineural hearing loss and Meniere's disease. Int J Immunogenet 2011;38:249–254.
  • Hiramatsu M, Teranishi M, Uchida Y, Nishio N, Suzuki H, Kato K, et al. Polymorphisms in genes involved in inflammatory pathways in patients with sudden sensorineural hearing loss. J Neurogenet 2012;26:387–396.
  • Nam SI, Yu GI, Kim HJ, Park KO, Chung JH, Ha E, Shin DH. A polymorphism at -1607 2G in the matrix metalloproteinase-1 (MMP-1) increased risk of sudden deafness in Korean population but not at -519A/G in MMP-1. Laryngoscope 2011;121:171–175.
  • Uchida Y, Sugiura S, Ando F, Shimokata H, Nakashima T. Association of the C677T polymorphism in the methylenetetrahydrofolate reductase gene with sudden sensorineural hearing loss. Laryngoscope 2010;120:791–795.
  • Uchida Y, Sugiura S, Nakashima T, Ando F, Shimokata H. Contribution of 1425G/A polymorphism in protein kinase C-Eta (PRKCH) gene and brain white matter lesions to the risk of sudden sensorineural hearing loss in a Japanese nested case-control study. J Neurogenet 2011;25:82–87.
  • Nishio N, Teranishi M, Uchida Y, Sugiura S, Ando F, Shimokata H, et al. Contribution of complement factor H Y402H polymorphism to sudden sensorineural hearing loss risk and possible interaction with diabetes. Gene 2012;499: 226–230.
  • Campbell CA, Della Santina CC, Meyer NC, Smith NB, Myrie OA, Stone EM, .Polymorphisms in KCNE1 or KCNE3 are not associated with Meniere disease in the Caucasian population. Am J Med Genet A 2010;152A:67–74.
  • Doi K, Sato T, Kuramasu T, Hibino H, Kitahara T, Horii A, et al. Meniere's disease is associated with single nucleotide polymorphisms in the human potassium channel genes, KCNE1 and KCNE3. ORL J Otorhinolaryngol Relat Spec 2005;67:289–293.
  • Kawaguchi S, Hagiwara A, Suzuki M. Polymorphic analysis of the heat-shock protein 70 gene (HSPA1A) in Meniere's disease. Acta Otolaryngol 2008;128:1173–1177.
  • Teggi R, Lanzani C, Zagato L, Delli Carpini S, Manunta P, Bianchi G, Bussi M. Gly460Trp alpha-adducin mutation as a possible mechanism leading to endolymphatic hydrops in Meniere's syndrome. Otol Neurotol 2008;29:824–828.
  • Nishio N, Teranishi M, Uchida Y, Sugiura S, Ando F, Shimokata H, et al. Polymorphisms in genes encoding aquaporins 4 and 5 and estrogen receptor alpha in patients with Meniere's disease and sudden sensorineural hearing loss. Life Sci 2013;92:541–546.
  • Huang Y, Teranishi M, Uchida Y, Nishio N, Kato K, Otake H, et al. Association between polymorphisms in genes encoding methylenetetrahydrofolate reductase and the risk of Ménière's disease. J Neurogenet 2013 in press.
  • AAO-HNS. Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngology Head Neck Surg 1995; 113:181.
  • Uchida Y, Nakashimat T, Ando F, Niino N, Shimokata H. Is there a relevant effect of noise and smoking on hearing?A population-based aging study. Int J Audiol 2005;44:86–91.
  • Yamada Y, Ando F, Niino N, Shimokata H. Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J Clin Endocrinol Metab 2003;88:3372–3378.
  • Hirota Y, Ohara T, Zenibayashi M, Kuno S, Fukuyama K, Teranishi T, et al. Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus. Metabolism 2007;56:656–661.
  • Nakashima T, Kuno K, Yanagita N. Evaluation of prostaglandin E1 therapy for sudden deafness. Laryngoscope 1989; 99:542–546.
  • Popa R, Anniko M, Takumida M, Arnold W. Localization of nitric oxide synthase isoforms in the human cochlea. Acta Otolaryngol 2001;121:454–459.
  • Heinrich UR, Maurer J, Gosepath K, Mann W. Immunoelectron microscopic localization of nitric oxide synthase III in the guinea pig organ of Corti. Eur Arch Otorhinolaryngol 1998;255:483–490.
  • Gosepath K, Gath I, Maurer J, Pollock JS, Amedee R, Forstermann U, Mann W. Characterization of nitric oxide synthase isoforms expressed in different structures of the guinea pig cochlea. Brain Res 1997;747:26–33.
  • Franz P, Hauser-Kronberger C, Bock P, Quint C, Baumgartner WD. Localization of nitric oxide synthase I and III in the cochlea. Acta Otolaryngol 1996;116:726–731.
  • Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, Smits P. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002;20:2023–2027.
  • Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991;88: 1663–1671.
  • Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986;8:37–44.
  • Rees DD, Palmer RM, Moncada S. Role of endothelium- derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A 1989;86:3375–3378.
  • Huang P L, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239–242.
  • Mannini L, Cecchi E, Fatini C, Marcucci R, Alessandriello Liotta A, Matucci-Cerinic M, et al. Clinical haemorheology and microcirculation. Ann Ist Super Sanita 2007;43: 144–155.
  • Fatini C, Mannini L, Sticchi E, Cecchi E, Bruschettini A, Leprini E, et al. eNOS gene affects red cell deformability: role of T-786C, G894T, and 4a/4b polymorphisms. Clin Appl Thromb Hemost 2005;11:481–488.
  • Heidari A, Behmanesh M, Sahraian MA, Meshkani R, Darvish H, Najmabadi H, Ohadi M. The human caveolin 1 gene upstream purine complex and neurodegeneration–a common signature. J Neuroimmunol 2011;236:106–110.
  • Chen Z, Bakhshi FR, Shajahan AN, Sharma T, Mao M, Trane A, et al. Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition. Mol Biol Cell 2012;23:1388–1398.
  • Yamada Y, Ando F, Shimokata H. Association of gene polymorphisms with blood pressure and the prevalence of hypertension in community-dwelling Japanese individuals. Int J Mol Med 2007;19:675–683.
  • Williams T M, Lisanti M P. The caveolin proteins. Genome Biol 2004;5:214.
  • Wiechmann AF, Sherry DM. Role of melatonin and its receptors in the vertebrate retina. Int Rev Cell Mol Biol 2013;300:211–242.
  • Kim JB, Jung JY, Ahn JC, Rhee CK, Hwang HJ. Antioxidant and anti-apoptotic effect of melatonin on the vestibular hair cells of rat utricles. Clin Exp Otorhinolaryngol 2009;2:6–12.
  • Lassegue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010;30:653–661.
  • Arca M, Conti B, Montali A, Pignatelli P, Campagna F, Barilla F, et al. C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery disease. Arterioscler Thromb Vasc Biol 2008;28:752–757.
  • Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K. Mitochondrial genotype associated with longevity. Lancet 1998;351:185–186.
  • Kokaze A, Ishikawa M, Matsunaga N, Yoshida M, Satoh M, Teruya K, et al. NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modifies the effects of alcohol consumption on risk for hypertension in middle-aged Japanese men. Hypertens Res 2007;30:213–218.
  • Wang D, Taniyama M, Suzuki Y, Katagiri T, Ban Y. Association of the mitochondrial DNA 5178A/C polymorphism with maternal inheritance and onset of type 2 diabetes in Japanese patients. Exp Clin Endocrinol Diabetes 2001;109:361–364.
  • Mukae S, Aoki S, Itoh S, Sato R, Nishio K, Iwata T, Katagiri T. Mitochondrial 5178A/C genotype is associated with acute myocardial infarction. Circ J 2003;67:16–20.
  • Takagi K, Yamada Y, Gong JS, Sone T, Yokota M, Tanaka M. Association of a 5178C–> A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals. Atherosclerosis 2004;175:281–286.
  • Ohkubo R, Nakagawa M, Ikeda K, Kodama T, Arimura K, Akiba S, et al. Cerebrovascular disorders and genetic polymorphisms: mitochondrial DNA5178C is predominant in cerebrovascular disorders. J Neurol Sci 2002;198:31–35.
  • Kokaze A, Ishikawa M, Matsunaga N, Karita K, Yoshida M, Shimada N, et al. Mitochondrial DNA 5178 C/A polymorphism influences the effects of habitual smoking on the risk of dyslipidemia in middle-aged Japanese men. Lipids Health Dis 2012;11:97.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.